| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |